Insights

Top performing ASX 200 healthcare shares in August

These ASX 200 healthcare shares topped the leaderboards in August.
The post Top performing ASX 200 healthcare shares in August appeared first on The Motley Fool Australia. –

August was a bumper month for ASX 200 healthcare shares with broad based buying across the sector.

The S&P/ASX 200 Health Care (INDEXASX: XHJ) index rallied 6.8% last month to an 18-month high and less than 3% away from all-time highs.

The solid performance was headlined by these top performing players.

Top performing ASX 200 healthcare shares in August

Nanosonics Ltd (ASX: NAN)

The Nanosonics share price rallied 23.5% in August to a 7-month high of $6.62.

Nanosonics delivered its FY21 results on Tuesday, 24 August when its share price surged 21.9% to $7.18.

The company delivered a relatively flat financial performance with revenues up 3% to $103.1 million while net profit after tax declined 15% to $8.6 million.

Encouragingly, management said the company experienced a “significant recovery” in the second half of FY21, with revenues bouncing 16.3% compared to 2H20 figures.

Management believes this momentum is likely to continue, expecting double-digit revenue growth figures in FY22.

Pro Medicus Limited (ASX: PME)

Pro Medicus is another ASX 200 healthcare share that surged after the release of its FY21 results.

The Pro Medicus share price rallied 15.6% to $65.35 on Wednesday, 18 August after the company reported a 19.5% increase in FY21 revenue to $67.9 million and a 33.7% lift in net profit after tax to $30.9 million.

Management hailed the year as “our biggest year in terms of both sales and implementations, laying the foundations for a further step-up in exam volumes in FY22”.

Despite the strong rally on the day of its results announcement, its gains would fade to 8.78% for the month of August.

Sonic Healthcare Ltd (ASX: SHL)

The Sonic Healthcare share price rallied 8.45% in August.

In contrast to the other top performing ASX 200 healthcare shares, the Sonic Healthcare share price fell almost 3% on the day of its FY21 results.

At face value, the company delivered an upbeat financial performance with revenue up 28% to $8.8 billion and net profit surging 149% to $1.3 billion.

However, the company flagged that its growth has been enhanced by COVID-19 testing revenue from its ~60 laboratories around the world.

Sonic Healthcare reported that COVID-19 PCR volumes were lower in the second half of the year versus the first half. However, volumes have been increasing again with the spread of the Delta variant.

The post Top performing ASX 200 healthcare shares in August appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of August 16th 2021

More reading

Sonic Healthcare (ASX:SHL) share price struggles despite COVID passport positioning
3 top ASX results from week four of reporting season

Here’s why the Pro Medicus (ASX:PME) share price is up 78% this year
Sonic Healthcare (ASX:SHL) share price hits record high at $43.43
Top brokers name 3 ASX shares to sell today

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Nanosonics Limited and Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited and Pro Medicus Ltd. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!